Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #12,251 to #12,300.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Yang L, et al. Oncogene (2010) cited as Ref 237 in DOI: 10.1038/s41392-020-0110-5 (Q9500)‏‎ (2 links)
  2. Berlin J, et al. Clin. Cancer Res. (2013) cited as Ref 606 in DOI: 10.1038/s41392-020-0110-5 (Q9869)‏‎ (2 links)
  3. Tocilizumab (chemical - MeSH supplementary concept)‏‎ (2 links)
  4. Wang H, et al. Cell Oncol. (Dordr.) (2016) cited as Ref 469 in DOI: 10.1038/s41392-020-0110-5 (Q9732)‏‎ (2 links)
  5. Qiu HB, et al, Zhonghua jie he he hu xi za zhi (2020), cited as Ref 19 in DOI: 10.1186/s13054-020-02882-x (Q10650)‏‎ (2 links)
  6. Pandolfi S, et al. Oncogene (2013) cited as Ref 245 in DOI: 10.1038/s41392-020-0110-5 (Q9508)‏‎ (2 links)
  7. Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5 (Q9877)‏‎ (2 links)
  8. angiotensin I converting enzyme (gene) (Q11098)‏‎ (2 links)
  9. Goicoechea SM, et al. Oncogene (2014) cited as Ref 477 in DOI: 10.1038/s41392-020-0110-5 (Q9740)‏‎ (2 links)
  10. Trzepacz PT, et al, J Neuropsychiatry Clin Neurosci (2001), cited as Ref 27 in DOI: 10.1186/s13054-020-02882-x (Q10658)‏‎ (2 links)
  11. Han B, et al. Cell Rep. (2015) cited as Ref 253 in DOI: 10.1038/s41392-020-0110-5 (Q9516)‏‎ (2 links)
  12. Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5 (Q9885)‏‎ (2 links)
  13. Chen WJ, et al. Nat. Commun. (2014) cited as Ref 485 in DOI: 10.1038/s41392-020-0110-5 (Q9748)‏‎ (2 links)
  14. Pandharipande PP, et al, Crit Care Med (2004), cited as Ref 35 in DOI: 10.1186/s13054-020-02882-x (Q10666)‏‎ (2 links)
  15. Takebe N, et al. Nat. Rev. Clin. Oncol. (2011) cited as Ref 261 in DOI: 10.1038/s41392-020-0110-5 (Q9524)‏‎ (2 links)
  16. Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5 (Q9893)‏‎ (2 links)
  17. Cavarretta IT, et al. Mol. Ther. (2010) cited as Ref 493 in DOI: 10.1038/s41392-020-0110-5 (Q9756)‏‎ (2 links)
  18. Cardio-Renal Syndrome (disease - MeSH descriptor) (Q10943)‏‎ (2 links)
  19. Li YC, et al, J Comp Neurol (2013), cited as Ref 43 in DOI: 10.1186/s13054-020-02882-x (Q10674)‏‎ (2 links)
  20. Zinke J, et al. Mol. Cancer (2015) cited as Ref 269 in DOI: 10.1038/s41392-020-0110-5 (Q9532)‏‎ (2 links)
  21. Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5 (Q9901)‏‎ (2 links)
  22. In the Southwest where medicine men are still lag. [IndianCountry/Health] (Q5999)‏‎ (2 links)
  23. Tu B, et al. Cancer Lett. (2012) cited as Ref 501 in DOI: 10.1038/s41392-020-0110-5 (Q9764)‏‎ (2 links)
  24. CD4 molecule (gene) (Q10885)‏‎ (2 links)
  25. Mengeling WL, et al, Am J Vet Res (1972), cited as Ref 51 in DOI: 10.1186/s13054-020-02882-x (Q10682)‏‎ (2 links)
  26. May MJ, et al. Semin. Cancer Biol. (1997) cited as Ref 277 in DOI: 10.1038/s41392-020-0110-5 (Q9540)‏‎ (2 links)
  27. Zhao J, et al. Pharmacol. Ther. (2016) cited as Ref 646 in DOI: 10.1038/s41392-020-0110-5 (Q9909)‏‎ (2 links)
  28. JK Scott kickoff for 63 yds Kalija Lipscomb return for 16 yds to the Vandy 18 (9/23/17)‏‎ (2 links)
  29. Peng D, et al. Cancer Res. (2016) cited as Ref 509 in DOI: 10.1038/s41392-020-0110-5 (Q9772)‏‎ (2 links)
  30. Baig AM, et al, ACS Chem Neurosci (2020), cited as Ref 59 in DOI: 10.1186/s13054-020-02882-x (Q10690)‏‎ (2 links)
  31. Karin M, et al. Cold Spring Harb. Perspect. Biol. (2009) cited as Ref 285 in DOI: 10.1038/s41392-020-0110-5 (Q9548)‏‎ (2 links)
  32. Wainwright EN, et al. Trends Cancer (2017) cited as Ref 654 in DOI: 10.1038/s41392-020-0110-5 (Q9917)‏‎ (2 links)
  33. Murai T, et al. Front. Immunol. (2015) cited as Ref 517 in DOI: 10.1038/s41392-020-0110-5 (Q9780)‏‎ (2 links)
  34. Kim LJ, et al, Brain Res (2015), cited as Ref 67 in DOI: 10.1186/s13054-020-02882-x (Q10698)‏‎ (2 links)
  35. Vanderbilt Stadium (Q298)‏‎ (2 links)
  36. Wang D, et al. Gastroenterology (2015) cited as Ref 293 in DOI: 10.1038/s41392-020-0110-5 (Q9556)‏‎ (2 links)
  37. Ricardo S, et al. J. Clin. Pathol. (2011) cited as Ref 662 in DOI: 10.1038/s41392-020-0110-5 (Q9925)‏‎ (2 links)
  38. Brent Cimaglia kickoff for 60 yds Henry Ruggs III return for 21 yds to the Alab 41 (10-21-17)‏‎ (2 links)
  39. Chow A, et al. Sci. Rep. (2014) cited as Ref 525 in DOI: 10.1038/s41392-020-0110-5 (Q9788)‏‎ (2 links)
  40. Girard TD, et al, Lancet Respir Med (2018), cited as Ref 75 in DOI: 10.1186/s13054-020-02882-x (Q10706)‏‎ (2 links)
  41. Han D, et al. Oncotarget (2015) cited as Ref 301 in DOI: 10.1038/s41392-020-0110-5 (Q9564)‏‎ (2 links)
  42. Vassilopoulos A, et al. Oncogene (2014) cited as Ref 670 in DOI: 10.1038/s41392-020-0110-5 (Q9933)‏‎ (2 links)
  43. Andrew R, et al. Eur. J. Cancer (2014) cited as Ref 533 in DOI: 10.1038/s41392-020-0110-5 (Q9796)‏‎ (2 links)
  44. Hsieh SJ, et al, Crit Care Med (2019), cited as Ref 83 in DOI: 10.1186/s13054-020-02882-x (Q10714)‏‎ (2 links)
  45. Quintas-Cardama A, et al. Clin. Cancer Res. (2013) cited as Ref 309 in DOI: 10.1038/s41392-020-0110-5 (Q9572)‏‎ (2 links)
  46. Fukamachi H, et al. PLoS ONE (2013) cited as Ref 678 in DOI: 10.1038/s41392-020-0110-5 (Q9941)‏‎ (2 links)
  47. Donnarumma E, et al. Oncotarget (2017) cited as Ref 541 in DOI: 10.1038/s41392-020-0110-5 (Q9804)‏‎ (2 links)
  48. Roder S, et al. Exp. Hematol. (2001) cited as Ref 317 in DOI: 10.1038/s41392-020-0110-5 (Q9580)‏‎ (2 links)
  49. Wang JC, et al. Theranostics (2019) cited as Ref 686 in DOI: 10.1038/s41392-020-0110-5 (Q9949)‏‎ (2 links)
  50. Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5 (Q9812)‏‎ (2 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)